Effect of Platelet-Rich Plasma Injection on Rotator Cuff Tear Repair
- Conditions
- Rotator cuff tear.Unspecified rotator cuff tear or rupture, not specified as traumaticM75.10
- Registration Number
- IRCT20240123060779N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Age range: 18 to 80 years old
Initial tear
Traumatic or degenerative tear with less than 50% thickness
Willingness to participate in the study
Secondary rotator cuff tear due to fracture or dislocation
Presence of dislocation during the study period
Rotator cuff tears that have previously undergone surgical repair or corrective arthroscopy
Diseases associated with upper limb pain such as arthritis, infection, carpal tunnel syndrome, cervical neuropathy
Localized malignancy
Systemic disorders such as uncontrolled diabetes and hypothyroidism, pregnancy, platelet count less than 125,000
Having definitive disability or inability to attend for follow-up after injection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of rotator cuff tear repair extent based on changes in percentage of tear. Timepoint: Before intervention and at 2 months and 6 months post-initiation of platelet-rich plasma injection. Method of measurement: Ultrasound imaging.;Determination of rotator cuff tear repair extent based on changes in mediolateral tear length. Timepoint: Before intervention and at 2 months and 6 months post-initiation of platelet-rich plasma injection. Method of measurement: Ultrasound imaging.;Determination of rotator cuff tear repair extent based on changes in pain level. Timepoint: Before intervention and at 2 months and 6 months post-initiation of platelet-rich plasma injection. Method of measurement: Ultrasound imaging.;Determination of rotator cuff tear repair extent based on changes in shoulder range of motion. Timepoint: Before intervention and at 2 months and 6 months post-initiation of platelet-rich plasma injection. Method of measurement: Ultrasound imaging.
- Secondary Outcome Measures
Name Time Method